BNGO | Bionano Genomics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	5.14 - 5.37
52 Week Range	4.75 - 81.00
Beta	2.10
Implied Volatility	496.40%
IV Rank	32.34%
Day's Volume	75,353
Average Volume	210,744
Shares Outstanding	2,330,400
Market Cap	12,490,944
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2018-08-21

Valuation
Profitability
Growth
Health
P/E Ratio	-0.04
Forward P/E Ratio	-4.94
EPS	-138.00
1YR Price Target	7.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	344
Country	USA
Website	BNGO

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

BNGO's peers: ISRG, LUCY, STXS, NXGL, MBOT, STAA, NVST, GMVD, BDX, WST, RMD, WHSI, BLFE, CEOS, POAI, STSS, GCTK, MHUA, POCI

*Chart delayed

Analyzing fundamentals for BNGO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see BNGO Fundamentals page.

Watching at BNGO technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on BNGO Technicals page.